Thrombosis Research 2012-10-01

Is there any need for a TAFI(a) inhibitor as thrombolytic drug?

Ellen Vercauteren, Ann Gils

Index: Thromb. Res. 130(4) , 574-5, (2012)

Full Text: HTML

Abstract


Related Compounds

Related Articles:

Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.

2011-05-01

[Eur. J. Med. Chem. 46 , 1483-98, (2011)]

Surface interactions of a homologous series of alpha,omega-amino acids on colloidal silver and gold.

1999-01-01

[Biospectroscopy 5(1) , 9-17, (1999)]

Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with omega-amino acid ligands.

1993-04-13

[Biochemistry 32(14) , 3540-8, (1993)]

The cationic locus on the recombinant kringle 2 domain of tissue-type plasminogen activator that stabilizes its interaction with omega-amino acids.

1992-12-01

[Biochemistry 31(47) , 11698-706, (1992)]

Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis.

2012-10-01

[Thromb. Res. 130(4) , e222-8, (2012)]

More Articles...